27,810 Shares in Humana Inc. (NYSE:HUM) Acquired by Kennondale Capital Management LLC

Kennondale Capital Management LLC bought a new position in shares of Humana Inc. (NYSE:HUM) during the fourth quarter, Holdings Channel.com reports. The fund bought 27,810 shares of the insurance provider’s stock, valued at approximately $7,056,000. Humana makes up 5.7% of Kennondale Capital Management LLC’s holdings, making the stock its 3rd biggest holding.

Other large investors have also recently made changes to their positions in the company. Transcend Capital Advisors LLC increased its stake in shares of Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after buying an additional 2,914 shares during the period. FNY Investment Advisers LLC boosted its holdings in Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after purchasing an additional 26,856 shares in the last quarter. Retirement Systems of Alabama boosted its holdings in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its holdings in Humana by 7.3% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after purchasing an additional 65,735 shares in the last quarter. Finally, PDT Partners LLC boosted its holdings in Humana by 190.0% in the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after purchasing an additional 2,660 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of the company’s stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the sale, the insider now owns 8,181 shares of the company’s stock, valued at $2,096,463.06. This represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.32% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on HUM shares. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $283.00 price target on shares of Humana in a report on Wednesday, February 12th. Piper Sandler upped their price target on Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. JPMorgan Chase & Co. decreased their price objective on Humana from $257.00 to $256.00 and set a “neutral” rating for the company in a report on Tuesday, February 18th. StockNews.com downgraded Humana from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price objective on shares of Humana in a report on Wednesday, February 12th. Nineteen research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $285.68.

Humana Trading Up 4.5 %

Shares of Humana stock opened at $264.39 on Tuesday. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $406.46. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68. The company’s 50-day simple moving average is $271.39 and its 200-day simple moving average is $278.89. The firm has a market cap of $31.91 billion, a price-to-earnings ratio of 26.57, a price-to-earnings-growth ratio of 2.05 and a beta of 0.57.

Humana (NYSE:HUM) last released its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, equities research analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.34%. The ex-dividend date of this dividend is Friday, March 28th. Humana’s dividend payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.